Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed Conditions
NCT00803192 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 44
Last updated 2012-03-16
Summary
Compare the rate and extent of absorption of famotidine 40 mg tablets, administered as 1 x 40 mg tablet under fed conditions.
Conditions
- Bioavailability
Interventions
- DRUG
-
Famotidine Tablets, 40 mg
Sponsors & Collaborators
-
Perrigo Company
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-06-30
- Primary Completion
- 2004-06-30
More Related Trials
-
Bioequivalence Study of FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET in Healthy Subjects Under Fasting Conditions
NCT01910090 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults
NCT06507904 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers
NCT06552624 ·Status: COMPLETED ·Phase: NA
-
Bioequivalency Study of Ranitidine Tablets 300 mg of Dr. Reddy's Under Fasting Conditions
NCT01131702 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions
NCT01161940 ·Status: COMPLETED ·Phase: PHASE1
-
Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed Condition
NCT01170182 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions
NCT00804401 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Rosuvastatin in Healthy Volunteers Under Fasting Condition
NCT05197517 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Non- Fasting Conditions
NCT01161927 ·Status: COMPLETED ·Phase: PHASE1
-
A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition
NCT01079065 ·Status: COMPLETED ·Phase: NA
-
Bioequivalence Study of Fosinopril 40mg Tablets Under Fed Conditions
NCT00776672 ·Status: COMPLETED ·Phase: NA
-
Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg
NCT00650195 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers
NCT06098742 ·Status: RECRUITING ·Phase: NA
-
Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed Conditions
NCT02605395 ·Status: COMPLETED ·Phase: PHASE4
-
BE Study of Gaster®D Tab 20mg (Manufacturer Changed)
NCT04123899 ·Status: UNKNOWN ·Phase: NA
-
Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed Condition
NCT01283932 ·Status: COMPLETED ·Phase: PHASE1
-
Single-Dose Fed Bioequivalence Study of Nisoldipine Extended-Release Tablets (40 mg; Mylan) and Sular® Extended-Release Tablets (40 mg; First Horizon) in Healthy Volunteers
NCT00979537 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition
NCT01283919 ·Status: COMPLETED ·Phase: PHASE1
-
Amlodipine 10 mg Tablets Under Fasting Conditions
NCT00841542 ·Status: COMPLETED ·Phase: PHASE1
-
Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg
NCT00649181 ·Status: COMPLETED ·Phase: PHASE1
-
Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fasting Conditions
NCT01170169 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study for Metoprolol Succinate ER Tablets 50 mg Under Fasting Condition
NCT01694797 ·Status: COMPLETED ·Phase: PHASE1
-
Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg
NCT00648219 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study
NCT01380431 ·Status: COMPLETED ·Phase: PHASE1
-
Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mg
NCT00649051 ·Status: COMPLETED ·Phase: PHASE1